Brief: Hyloris Announces Approval Of Maxigesic IV In UK And Ireland
Oct 19 (Reuters) - HYLORIS PHARMACEUTICALS SA HYL.BR :
* HYLORIS ANNOUNCES APPROVAL OF MAXIGESIC IV IN THE UK AND
IRELAND
* KENSINGTON PHARMACEUTICALS LTD., DISTRIBUTOR FOR UK, AND
JED
PHARMA LTD, DISTRIBUTOR IN IRELAND, ARE NOW GEARING UP TO
COMMENCE SALES IN Q1 OF 2022
Source text for Eikon: ID:nGNE7fPF90
Further company coverage: HYL.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Hyloris Pharmaceuticals SA
See all newsEurope Research Roundup: Akzo Nobel, MTU Aero Engines, Symrise
Brief: Hyloris Pharmaceuticals Says It Obtains Exclusive License Rights In Europe & Turkey From Arbormed For Its Wilson's Disease Therapy
Brief: Hyloris Announces Partnership With Rosemont Pharmaceuticals For Atomoxetine Oral Solution In The U.S.
Brief: Hyloris Announces Positive Study Results For Dofetilide IV
Brief: Hyloris Pharmaceuticals SA Says HY 2024 Revenues (Royalties And Milestones) Increased To EUR 4,2 Million